Stock Price
22.45
Daily Change
6.00%
Yearly
-58.39%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Eisai 5,917.00 -131.00 -2.17% -24.62%
Acadia Pharmaceuticals 22.45 1.27 6.00% -58.39%
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
ALKERMES 25.56 1.56 6.50% 11.76%
Alnylam Pharmaceuticals 136.53 0.12 0.09% -22.29%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Aptinyx Inc 3.01 0.15 5.24% -24.75%
Arena Pharmaceuticals 89.95 -0.53 -0.59% 15.32%
Biogen 224.69 4.17 1.89% -18.45%
BioMarin Pharmaceutical 86.22 1.57 1.85% -3.09%
Bristol-Myers Squibb 62.61 -0.93 -1.46% -3.42%
Cara Therapeutics 11.77 -0.18 -1.51% -40.10%
Corcept Therapeutics 17.78 0.59 3.43% -37.75%
Cytokinetics 31.47 1.17 3.86% 51.01%
GW Pharmaceuticals 218.96 0 0% 108.53%
Intercept Pharmaceuticals 15.61 0.27 1.72% -52.90%
Incyte Corp 75.34 0.55 0.74% -25.03%
Intra Cellular Therapies 44.34 1.68 3.94% 30.72%
J&J 162.97 -1.90 -1.15% -1.81%
Eli Lilly 240.42 -2.64 -1.09% 13.22%
Moderna Inc 157.30 -2.77 -1.73% 7.01%
Marinus Pharmaceuticals 10.67 0.39 3.79% -22.74%
Neurocrine Biosciences 75.86 0.76 1.01% -36.47%
Pfizer 51.54 -1.25 -2.37% 38.25%
Prothena 35.47 0.09 0.26% 157.59%
PTC Therapeutics 40.12 1.30 3.35% -36.84%
Ultragenyx Pharmaceutical 67.96 0.79 1.18% -53.69%
Seattle Genetics 129.55 2.00 1.57% -28.08%
Sarepta Therapeutics 67.30 3.83 6.03% -29.98%
Vanda Pharmaceuticals 14.74 0.55 3.88% 3.33%
Vertex Pharmaceuticals 229.68 1.60 0.70% -4.82%
Zogenix 25.93 -0.02 -0.08% 32.16%

Indexes Price Day Year
NASDAQ 13505 -349.74 -2.52% -0.89%
US2000 1984 -49.20 -2.42% -7.70%

Acadia Pharmaceuticals
Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders. The Company's product pipeline includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist/antagonist, preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. Trofinetide is a synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome. ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).